The idea that young blood has almost magical properties took place at the dawn of modern society. However, some experiments in this area are still ongoing. Of course, no one goes down to medieval rituals with blood transfusions of babies to old people. But not so long ago, the Californian company Alkahest, during a preliminary test phase, was able to prove that specially prepared plasma of young blood helps to cope with the manifestations of Alzheimer's disease.
How blood can help cure Alzheimer's
Alkahest has been developing treatments for neurodegenerative diseases for several years. Scientists of the company place great emphasis on special proteins called "chronokines". Chronokines are found in blood plasma and, according to some reports, have a positive effect on the central nervous system, restoring the functioning of brain neurons and promoting the regeneration of stem cells. It is known that the content of chronokines changes with age, significantly decreasing in old age. It is this gap that the Alkahest scientists decided to fill.
In a recent study, scientists recruited a group of 40 patients suffering from Alzheimer's disease. Scientists wanted to check whether their predictions would prove to be true that if a person is injected with a fraction of blood plasma with chronokines GRF6019 placed in it, it will slow down the course of the disease. It is worth noting that this is already the second phase of testing, and during the first one on laboratory animals the result was positive. This time, all 40 participants in the experiment were injected intravenously with therapeutic plasma with chronokines GRF6019 for five days. The procedure was repeated after 12 weeks. At the same time, before and after the course of treatment, patients underwent several of the most common tests to assess the depth of cognitive impairment in Alzheimer's disease and senile dementia.
As a result, it turned out that after 12 weeks of treatment, the patient's indicators on these tests remained at the same level. This may sound like a bad result, but in reality it is far from the case. The fact is that in 12 weeks the test results should have decreased, since during this time the processes of brain degeneration during the normal course of the disease simply could not slow down.
Vladimir Kuznetsov
Promotional video:
